For much of the 20th century it was thought that the adult brain was incapable of regeneration. This view has since shifted dramatically and neurogenesis – the birth of new neurons – is now a widely ...

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

Rapid advances in sequencing technologies have transformed our ability to diagnose human genetic disorders, yet many patients still lack a molecular ...

In a new genetic study, scientists have charted the rise of 214 human diseases across ancient Europe and Asia. By Carl Zimmer To prepare for future pandemics, scientists look to the past for clues.

The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations have limited advancement of the field. While existing editing ...

Current data suggests that drug development, from the start of a research program to FDA approval, can take anywhere from 10 to 17 years. However, there is a need to speed up this lengthy drug ...